Cargando…
Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer
SETDB1 is a key histone lysine methyltransferase involved in gene silencing. The SETDB1 gene is amplified in human lung cancer, where the protein plays a driver role. Here, we investigated the clinical significance of SETDB1 expression in the two major forms of human non-small cell lung carcinoma (N...
Autores principales: | Cruz-Tapias, Paola, Zakharova, Vlada, Perez-Fernandez, Oscar M., Mantilla, William, Ramírez-Clavijo, Sandra, Ait-Si-Ali, Slimane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721806/ https://www.ncbi.nlm.nih.gov/pubmed/31398867 http://dx.doi.org/10.3390/cancers11081134 |
Ejemplares similares
-
The cytoplasmic fraction of the histone lysine methyltransferase Setdb1 is essential for embryonic stem cells
por: Rapone, Roberta, et al.
Publicado: (2023) -
The H3K9 Methylation Writer SETDB1 and Its Reader MPP8 Cooperate to Silence Satellite DNA Repeats in Mouse Embryonic Stem Cells
por: Cruz-Tapias, Paola, et al.
Publicado: (2019) -
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016) -
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2021)